Top healthcare stocks this month include Viking Therapeutics Inc., Cabaletta Bio Inc., and Prometheus Biosciences Inc., shares of which have soared more than 600% in the last year on promising early data for new therapeutic products or acquisition offers.
Healthcare stocks—represented by the Health Care Select Sector SPDR ETF (XLV), an exchange-traded fund (ETF)—fell 2% over the past year, compared with a 2% increase for the Russell 1000.
Here are the top three healthcare stocks in the following categories: best value, fastest growth, and most momentum. Benchmark data are as of June 7, while company data below are as of May 5.
ស្តុកសុខភាពតម្លៃល្អបំផុត
These are the healthcare stocks with the lowest 12-month trailing price-to-earnings (P/E) ratio. Because profits can be returned to shareholders in the form of dividends and buybacks, a low P/E ratio shows that you’re paying less for each dollar of profit generated.
| ស្តុកសុខភាពតម្លៃល្អបំផុត | |||
|---|---|---|---|
| តម្លៃ ($) | មូលធនប័ត្រទីផ្សារ (Market Cap) ($B) | អនុបាត ១២ ខែជាប់ / អ | |
| Theravance Biopharma Inc. (TBPH) | 11.14 | 0.6 | 1.0 |
| Intercept Pharmaceuticals Inc. (ICPT) | 11.19 | 0.5 | 1.8 |
| Zymeworks Inc. (ZYME) | 8.94 | 0.6 | 3.5 |
ប្រភព៖ YCharts
- Theravance Biopharma Inc.៖ Theravance is a biopharmaceutical company in the Cayman Islands that develops and manufactures respiratory medicines such as Yupelri and Trelergy to treat COPD.
- Intercept Pharmaceuticals Inc.: Intercept is a biopharmaceutical company that develops and sells products to treat chronic liver diseases. Intercept shares have lost almost 18% of their value in the last year amid relatively modest revenue gains.
- Zymeworks Inc.: Zymeworks is a Canadian clinical-stage biotech company that develops therapeutics for the treatment of cancers. The company’s revenue skyrocketed by more than 1,700% in the latest quarter as it received support from its collaborator Jazz Pharmaceuticals PLC (JAZZ) to develop and commercialize zanidatamab, a drug candidate for the treatment of gastroesophageal adenocarcinoma.
ភាគហ៊ុនថែទាំសុខភាពដែលរីកលូតលាស់លឿនបំផុត។
These are the top healthcare stocks as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly year-over-year (YOY) percentage revenue growth and most recent quarterly YOY earnings-per-share (EPS) growth.
ទាំងការលក់ និងប្រាក់ចំណូល គឺជាកត្តាសំខាន់ក្នុងភាពជោគជ័យរបស់ក្រុមហ៊ុន។ ដូច្នេះ ចំណាត់ថ្នាក់ក្រុមហ៊ុនដោយរង្វាស់កំណើនតែមួយធ្វើឱ្យចំណាត់ថ្នាក់ងាយនឹងកើតមានភាពមិនប្រក្រតីនៃគណនេយ្យនៃត្រីមាសនោះ (ដូចជាការផ្លាស់ប្តូរច្បាប់ពន្ធ ឬថ្លៃដើមរៀបចំរចនាសម្ព័ន្ធឡើងវិញ) ដែលអាចធ្វើឱ្យតួលេខមួយ ឬមិនតំណាងផ្សេងទៀតនៃអាជីវកម្មជាទូទៅ។ ក្រុមហ៊ុនដែលមាន EPS ប្រចាំត្រីមាស ឬកំណើនប្រាក់ចំណូលលើសពី 1,000% មិនត្រូវបានរាប់បញ្ចូលជាក្រុមហ៊ុនលើស។
| ភាគហ៊ុនថែទាំសុខភាពដែលរីកលូតលាស់លឿនបំផុត។ | ||||
|---|---|---|---|---|
| តម្លៃ ($) | តម្លៃទីផ្សារ ($ B) | កំណើន EPS (%) | កំណើនប្រាក់ចំណូល (%) | |
| Dr Reddy’s Laboratories Ltd. (RDY) | 56.41 | 9.4 | 904.0 | 6.0 |
| Royalty Pharma PLC (RPRX) | 33.31 | 14.9 | 533.3 | 21.7 |
| AstraZeneca PLC (AZN) | 73.20 | 226.9 | 364.0 | -4.5 |
ប្រភព៖ YCharts
- Dr Reddy’s Laboratories Ltd.: Dr Reddy’s is an Indian pharmaceutical company that produces generics and biosimilars for gastrointestinal and cardiovascular disorders, pain management, and other therapeutic needs. Particularly strong growth in both the company’s India and North America segments contributed to significant EPS growth in the most recent quarter.
- Royalty Pharma PLC: Royalty Pharma is a biopharmaceuticals royalties company that partners with companies to fund late-stage clinical trials and also purchases existing royalties for therapeutics. Royalty’s financial performance in the latest quarter was driven by momentum from the FDA’s approval of Pfizer’s migraine treatment Zavzpret, in which the company maintains a royalty interest.
- AstraZeneca PLC: AstraZeneca is a British-Swedish healthcare holding company that, through subsidiaries, researches, manufactures, and markets pharmaceutical products for gastrointestinal, central nervous system, and cardiovascular disorders, among others. AstraZeneca’s revenue declined in the first quarter of 2023 as sales of its COVID-19 products fell. Nonetheless, EPS quadrupled on reductions in operating costs and foreign exchange benefits.
ភាគហ៊ុនថែទាំសុខភាពជាមួយនឹងសន្ទុះបំផុត។
ទាំងនេះគឺជាភាគហ៊ុនថែទាំសុខភាពដែលមានប្រាក់ចំណូលសរុបខ្ពស់បំផុតក្នុងរយៈពេល 12 ខែចុងក្រោយនេះ។
| ភាគហ៊ុនថែទាំសុខភាពជាមួយនឹងសន្ទុះបំផុត។ | |||
|---|---|---|---|
| តម្លៃ ($) | តម្លៃទីផ្សារ ($ B) | ប្រាក់ចំណេញសរុបសរុប ១២ ខែជាប់គ្នា (%) | |
| Viking Therapeutics Inc. (VKTX) | 23.07 | 2.3 | 885.9 |
| Cabaletta Bio Inc. (CABA) | 11.94 | 0.5 | 840.2 |
| Prometheus Biosciences Inc. (RXDX) | 198.80 | 9.5 | 614.9 |
| សន្ទស្សន៍រ័សុល ២០០០ | N / A | N / A | 2.3 |
| វិស័យជ្រើសរើសការថែទាំសុខភាព SPDR ETF (XLV) | N / A | N / A | -1.7 |
ប្រភព៖ YCharts
- Viking Therapeutics Inc.: Viking is a biopharmaceuticals company that develops products for patients with metabolic and endocrine disorders. The stock jumped 69% in a day in late March after the company reported promising early trial data for an obesity drug.
- Cabaletta Bio Inc.: Cabaletta is a biotech company that discovers and develops therapies for autoimmune diseases. Shares have risen steadily since October the company said it was pursuing clinical trials of CABA-201 for use in treating autoimmune disorders.
- Prometheus Biosciences Inc.: Prometheus is a biosciences company that develops diagnostics and therapeutics for inflammatory bowel disease. The stock has surged since Merck & Co. Inc. (MRK) announced in late April plans to acquire Prometheus for about $11 billion.
អត្ថប្រយោជន៍នៃភាគហ៊ុនថែទាំសុខភាព
An aging baby boomer population is creating additional demand for medical products and services, underpinning growth expectations for the healthcare sector. According to the Centers for Medicare and Medicaid Services, U.S. national healthcare expenditure is expected to reach $6.8 trillion by 2030.
A key advantage of the healthcare sector is consistent demand. The overall demand for healthcare products and services is likely to remain steady and to even increase as populations age. This makes healthcare stocks a potential defensive play.
At the same time, rapidly developing technologies also provide opportunities for both short- and long-term growth potential in the industry. It is also not uncommon for individual healthcare companies to see massive surges in stock price upon the announcement of promising clinical trials or the release of a new therapeutic with strong potential.
និន្នាការសំខាន់ៗក្នុងការថែទាំសុខភាព
The pandemic and technological advances have accelerated several key trends across the healthcare sector that provide potential opportunities for investors, among them telehealth and healthcare wearables.
Telehealth៖ Telehealth ភ្ជាប់អ្នកជំងឺជាមួយអ្នកជំនាញសុខភាពដោយប្រើការហៅជាវីដេអូ និងកម្មវិធីសុខភាព។ សេវាកម្មបែបនេះអនុញ្ញាតឱ្យប្រជាជនក្នុងតំបន់ដែលមិនសូវទទួលសេវា ឬអ្នកដែលមិនអាចធ្វើដំណើរបានយ៉ាងងាយស្រួលដើម្បីទទួលបានការណែនាំផ្នែកវេជ្ជសាស្រ្តនៅក្នុងផ្ទះ ឬកន្លែងធ្វើការរបស់ពួកគេ។
A survey conducted by the Bipartisan Policy Center showed that 63% of respondents had used telehealth as a preventative service, for a prescription refill, or for a routine visit for a chronic illness. Moreover, eight in 10 surveyed said their primary health issue was resolved and that they would likely use telehealth in the future.
Investors can gain exposure to telehealth through stocks including Teladoc Health Inc. (TDOC), Doximity Inc. (DOCS), and American Well Corp. (AMWL).
ឧបករណ៍ថែទាំសុខភាព: Wearable electronic devices allow consumers or patients to wear technology that collects their personal health and fitness data. Healthcare wearables can send a user’s health information in real-time to a doctor or other health professional for regular monitoring.
ឧបករណ៍ពាក់ថែទាំសុខភាពដែលពេញនិយមមួយចំនួនមានដូចជា នាឡិកាសុខភាពឆ្លាតវៃ ម៉ូនីទ័រ electrocardiogram (ECG) ឧបករណ៍វាស់សម្ពាធឈាម និងឧបករណ៍ចាប់សញ្ញាជីវគីមី។ ការស្ទង់មតិដែលធ្វើឡើងដោយ Insider Intelligence បានរកឃើញថា ការប្រើប្រាស់ឧបករណ៍ថែទាំសុខភាពរបស់អ្នកប្រើប្រាស់របស់សហរដ្ឋអាមេរិកបានកើនឡើងដល់ 33% ក្នុងឆ្នាំ 2022 ពី 9% កាលពីបួនឆ្នាំមុន។
Key stocks involved in healthcare wearables include Garmin Ltd. (GRMN), Wearable Health Solutions Inc. (WHSI), and Apple Inc. (AAPL).
មតិ យោបល់ និងការវិភាគដែលបានបង្ហាញនៅលើ Investopedia គឺសម្រាប់គោលបំណងព័ត៌មានតាមអ៊ីនធឺណិត។ សូមអានការធានា និងការទទួលខុសត្រូវរបស់យើងសម្រាប់ព័ត៌មានបន្ថែម។
គិតត្រឹមថ្ងៃដែលអត្ថបទនេះត្រូវបានសរសេរ អ្នកនិពន្ធមិនមានភាគហ៊ុនណាមួយខាងលើទេ។
Source: https://www.investopedia.com/top-healthcare-stocks-june-2023-7509401?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo